Home / Auditor changes / SOLENO THERAPEUTICS INC
Filed 2025-04-18 路 Form 8-K 路 Accession 0001193125-25-085810 mid
Price before filing: $69.98 (2025-04-17 close, split/dividend-adjusted)
Market cap at flag: $3.07B (2025-04-17) 路 Latest: $2.76B (2026-05-18)
| Window | SLNO | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +8.0% | +13.0% | -5.0% | 2025-05-19 |
| 90 days | +25.2% | +19.7% | +5.6% | 2025-07-17 |
| 180 days | -3.3% | +27.1% | -30.4% | 2025-10-15 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 8 insiders sold $199.8M (72 sales)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-03-26 | Vivo Opportunity, LLC (+1 joint filer) 10% owner | Sale | 400,000 | $65.80 | $26.3M | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 14,183 | $65.97 | $936K | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 23,095 | $66.79 | $1.5M | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 41,989 | $67.70 | $2.8M | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 55,234 | $68.79 | $3.8M | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 31,980 | $69.84 | $2.2M | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 3,291 | $70.73 | $233K | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 4,782 | $71.74 | $343K | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 732 | $72.64 | $53K | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 106,471 | $65.81 | $7.0M | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 209,689 | $66.33 | $13.9M | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 8,423 | $67.37 | $567K | no | Form 4 |
| 2025-03-27 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director | Sale | 199,226 | $69.30 | $13.8M | no | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 1,418 | $65.97 | $94K | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 2,310 | $66.79 | $154K | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 4,199 | $67.70 | $284K | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 5,524 | $68.79 | $380K | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 3,198 | $69.84 | $223K | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 329 | $70.73 | $23K | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 478 | $71.74 | $34K | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 73 | $72.64 | $5K | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 46,214 | $66.39 | $3.1M | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 24,776 | $67.47 | $1.7M | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 24,989 | $70.18 | $1.8M | yes | Form 4 |
| 2025-03-27 | Hirano Patricia C SEE REMARKS | Sale | 15,145 | $72.50 | $1.1M | yes | Form 4 |
| 2025-04-18: red flag filed | |||||||
Showing 25 of 72 transactions.
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-01-18 to 2025-05-18. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"On April 17, 2025, Marcum resigned as the Company's independent registered public accounting firm, and on April 18, 2025, CBIZ CPAs was engaged to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2025, effective beginning with the review of the Company's condensed consolidated financial statements for the quarter ended March 31, 2025."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: resigned
Disagreements reported: no
Former auditor: Marcum LLP · New auditor: CBIZ CPAs P.C.
Why this score: auditor resigned
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.